UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 37

Sortiert nach

Direct and Indirect Costs of Non-Vertebral Fracture Patients with Osteoporosis in the US

PharmacoEconomics, 2010-05, Vol.28 (5), p.395-409

2010

Link zum Volltext

Verfügbarkeit prüfen

Classifying Patients by Antipsychotic Adherence Patterns Using Latent Class Analysis: Characteristics of Nonadherent Groups in the California Medicaid (Medi-Cal) Program

Value in health, 2008, Vol.11 (1), p.48-56

2008

Link zum Volltext

Verfügbarkeit prüfen

Cost and utilization of healthcare services for hip and knee replacement

Journal of medical economics, 2013-07, Vol.16 (7), p.888-896

2013

Link zum Volltext

Verfügbarkeit prüfen

Pharmacological treatment and other predictors of treatment outcomes in previously untreated patients with schizophrenia: results from the European Schizophrenia Outpatient Health Outcomes (SOHO) study

International clinical psychopharmacology, 2005-07, Vol.20 (4), p.199

2005

Link zum Volltext

Verfügbarkeit prüfen

Olanzapine versus risperidone. A prospective comparison of clinical and economic outcomes in schizophrenia

PharmacoEconomics, 2000-12, Vol.18 (6), p.567-579

2000

Link zum Volltext

Verfügbarkeit prüfen

Subjective response to antipsychotic treatment and compliance in schizophrenia. A naturalistic study comparing olanzapine, risperidone and haloperidol (EFESO Study)

BMC psychiatry, 2001-12, Vol.1 (1), p.7-7, Article 7

2001

Link zum Volltext

Verfügbarkeit prüfen

A Modeled Economic Evaluation Comparing Atomoxetine with Stimulant Therapy in the Treatment of Children with Attention-Deficit/Hyperactivity Disorder in the United Kingdom

Value in health, 2008-05, Vol.11 (3), p.376-388

2008

Link zum Volltext

Verfügbarkeit prüfen

Clinical and economic outcomes of olanzapine compared with haloperidol for schizophrenia. Results from a randomised clinical trial

PharmacoEconomics, 1999-05, Vol.15 (5), p.469-480

1999

Link zum Volltext

Verfügbarkeit prüfen

Open-label olanzapine treatment in bipolar I disorder: clinical and work functional outcomes

Current medical research and opinion, 2006-05, Vol.22 (5), p.961-966

2006

Link zum Volltext

Verfügbarkeit prüfen

Use of concomitant medication with antipsychotic treatment in outpatients with schizophrenia: Results from the European Schizophrenia Outpatients Health Outcomes (SOHO) study

Progress in neuro-psychopharmacology & biological psychiatry, 2005-07, Vol.29 (6), p.972-982

2005

Link zum Volltext

Verfügbarkeit prüfen

Frequency of hospitalisations and inpatient care costs of manic episodes in patients with bipolar I disorder in France

PharmacoEconomics, 2003-01, Vol.21 (15), p.1081-1090

2003

Link zum Volltext

Verfügbarkeit prüfen

Costs of bipolar disorder

PharmacoEconomics, 2003-01, Vol.21 (9), p.601-622

2003

Link zum Volltext

Verfügbarkeit prüfen

A review of health-related quality-of-life measures used in end-stage renal disease

Clinical therapeutics, 1996-09, Vol.18 (5), p.887-938

1996

Link zum Volltext

Verfügbarkeit prüfen

Treatment patterns and resource utilization and costs among patients with pulmonary arterial hypertension in the United States

Journal of medical economics, 2010-09, Vol.13 (3), p.393-402

2010

Link zum Volltext

Verfügbarkeit prüfen

Initial treatment choice in depression: impact on medical expenditures

PharmacoEconomics, 2000-04, Vol.17 (4), p.371-382

2000

Link zum Volltext

Verfügbarkeit prüfen

Health State Utilities for Childhood Attention-Deficit/Hyperactivity Disorder Based on Parent Preferences in the United Kingdom

Medical decision making, 2005-01, Vol.25 (1), p.56-70

2005

Link zum Volltext

Verfügbarkeit prüfen

Unit costs in international economic evaluations: resource costing of the Schizophrenia Outpatient Health Outcomes Study

Acta psychiatrica Scandinavica, 2003-05, Vol.107 (s416), p.41-47

2003

Link zum Volltext

Verfügbarkeit prüfen

Rasch Model Analysis to Test the Cross-Cultural Validity of the EUROQOL-5D (EQ-5D) in the Schizophrenia Outpatient Health Outcomes (SOHO) Study

Quality of life research, 2002-11, Vol.11 (7), p.658-658

2002

Link zum Volltext

Verfügbarkeit prüfen

PII: S0149-2918(99)80063-0

Clinical therapeutics, 1999, Vol.21 (5), p.917-924

1999

Link zum Volltext

Verfügbarkeit prüfen

A Framework for Drug Utilization Evaluation in Depression: Insights from Outcomes Research

Medical care, 1999-04, Vol.37 (4), p.AS67-AS76

1999

Link zum Volltext

Verfügbarkeit prüfen

Sertraline. A pharmacoeconomic evaluation of its use in depression

PharmacoEconomics, 1997-04, Vol.11 (4), p.377-378

1997

Link zum Volltext

Verfügbarkeit prüfen

Religion Is Raced: Understanding American Religion in the Twenty-First Century

1, 2020

Link zum Volltext

Verfügbarkeit prüfen

Religious Influences on Understandings of Racial Inequality in the United States

Social problems (Berkeley, Calif.), 2007-05, Vol.54 (2), p.263-288

2007

Link zum Volltext

Verfügbarkeit prüfen

Chemosensitivity, Cardiovascular Risk, and the Ventilatory Response to Exercise in COPD

PloS one, 2016-06, Vol.11 (6), p.e0158341-e0158341

2016

Link zum Volltext

Verfügbarkeit prüfen

Shared Visions? Diversity and Cultural Membership in American Life

Social problems (Berkeley, Calif.), 2010-05, Vol.57 (2), p.175-204

2010

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 37

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(31)
Mit Volltextzugriff
(34)

Publikationsform

Sprache

Englisch
(36)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

Humans
(21)
Science & Technology
(20)
Life Sciences & Biomedicine
(19)
Social Sciences
(15)
Female
(12)
Male
(12)
Health Care Sciences & Services
(11)
Health Policy & Services
(11)
Pharmacology & Pharmacy
(10)
Adult
(9)
Business & Economics
(9)
Economics
(9)
Middle Aged
(9)
Health Technology Assessment
(7)
Schizophrenia
(7)
Antipsychotic Agents - Therapeutic Use
(6)
Biological And Medical Sciences
(6)
Medical Sciences
(6)
Prospective Studies
(6)
Schizophrenia - Drug Therapy
(6)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Direct and Indirect Costs of Non-Vertebral Fracture Patients with Osteoporosis in the US

Classifying Patients by Antipsychotic Adherence Patterns Using Latent Class Analysis: Characteristics of Nonadherent Groups in the California Medicaid (Medi-Cal) Program

Cost and utilization of healthcare services for hip and knee replacement

Pharmacological treatment and other predictors of treatment outcomes in previously untreated patients with schizophrenia: results from the European Schizophrenia Outpatient Health Outcomes (SOHO) study

Olanzapine versus risperidone. A prospective comparison of clinical and economic outcomes in schizophrenia

Subjective response to antipsychotic treatment and compliance in schizophrenia. A naturalistic study comparing olanzapine, risperidone and haloperidol (EFESO Study)

A Modeled Economic Evaluation Comparing Atomoxetine with Stimulant Therapy in the Treatment of Children with Attention-Deficit/Hyperactivity Disorder in the United Kingdom

Clinical and economic outcomes of olanzapine compared with haloperidol for schizophrenia. Results from a randomised clinical trial

Open-label olanzapine treatment in bipolar I disorder: clinical and work functional outcomes

Use of concomitant medication with antipsychotic treatment in outpatients with schizophrenia: Results from the European Schizophrenia Outpatients Health Outcomes (SOHO) study

Frequency of hospitalisations and inpatient care costs of manic episodes in patients with bipolar I disorder in France

Costs of bipolar disorder

A review of health-related quality-of-life measures used in end-stage renal disease

Treatment patterns and resource utilization and costs among patients with pulmonary arterial hypertension in the United States

Initial treatment choice in depression: impact on medical expenditures

Health State Utilities for Childhood Attention-Deficit/Hyperactivity Disorder Based on Parent Preferences in the United Kingdom

Unit costs in international economic evaluations: resource costing of the Schizophrenia Outpatient Health Outcomes Study

Rasch Model Analysis to Test the Cross-Cultural Validity of the EUROQOL-5D (EQ-5D) in the Schizophrenia Outpatient Health Outcomes (SOHO) Study

PII: S0149-2918(99)80063-0

A Framework for Drug Utilization Evaluation in Depression: Insights from Outcomes Research

Sertraline. A pharmacoeconomic evaluation of its use in depression

Religion Is Raced: Understanding American Religion in the Twenty-First Century

Religious Influences on Understandings of Racial Inequality in the United States

Chemosensitivity, Cardiovascular Risk, and the Ventilatory Response to Exercise in COPD

Shared Visions? Diversity and Cultural Membership in American Life

Suchergebnisse filtern